Dynavax Technologies | Custo De Mercadoria Vendida



Cost Of Sales Alterar Data
AbbVie USD 4.4B 184M 2024-12
Adma Biologics USD 54.22M 5.96M 2024-12
Amgen USD 3.11B 198M 2024-12
AstraZeneca USD 2.72B 263M 2024-12
Biogen USD 583.5M 55.2M 2024-12
BioMarin Pharmaceutical USD 136.14M 52.32M 2024-12
Bristol-Myers Squibb USD 3.21B 356M 2024-12
Dynavax Technologies USD 13.41M 326K 2024-12
Gilead Sciences USD 1.58B 7M 2024-12
Glaxosmithkline GBP 2.52B 199M 2024-12
Merck USD 3.71B 181M 2024-12
Neurocrine Biosciences USD 9.3M 1.3M 2024-12
Novartis USD 3.32B 90M 2024-12
Pfizer USD 5.65B 781M 2024-12
Regeneron Pharmaceuticals USD 565.4M 74.3M 2024-12
Roche Holding CHF 4.13B 393.5M 2024-12
Sarepta Therapeutics USD 132.3M 40.61M 2024-12
TG Therapeutics USD 15.4M 6.06M 2024-12
Vertex Pharmaceuticals USD 423.4M 30.8M 2024-12



Dynavax Technologies Custo De Mercadoria Vendida - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Apr 2025.